Coronavirus vaccine campaign is to gradually gain momentum across the world.According to the Our World in Data statistical web site at the University of Oxford, ten different vaccines have been rolled out in countries.
At the same time, according to the WHO, more than 200 additional vaccine candidates are in development, of which more than 60 are in clinical development.
As of March 9, more than 309.3 million vaccine doses have been administered worldwide, equal to 4 doses for every 100 people. There is already a stark gap between vaccination programs in different countries and different continents, the paper Tracking Coronavirus Vaccinations Around the World, published by The New York Times, reads.
In all national vaccination programs, the most vulnerable populations are the highest priority, and most countries have focused on such groups that include people aged 60 to 70 and over; doctors and nurses.
In Israel, doctors and nursing homes were the first in the vaccination campaign list. Israel leads the world in terms of the number of doses per head of population, with 99.7 doses given out for every 100 people. In vaccinations by country, the Seychelles, UAE, Great Britain, Maldives, Bahrain, Chile, USA, Serbia, Malta, etc. are following Israel.
The Pfizer-BioNTech vaccine that was found to be 95% effective at preventing coronavirus infection is used in 70 countries currently.More than 2 million Israelis have received the first dose of the BioNTech-Pfizer.
According to the Israel’s Prime Minister, Back to Life campaign continues to vaccinate all Israeli citizens and the country eyes to be the first in the world to open the economy widely.
The importance of effective vaccination is related not only the human life and health, but to the perspectives for economic development.So, experts interviewed by Bloomberg believe that the slow pace of vaccination in the EU countries and the continuing restrictions due to COVID-19 have a negative impact on the recovery of the EU economy and cause concern for investors.
It is informed, a delay of 1-2 months would amount to a 50-100 billion-euro blow in extended lockdowns and restrictions in the EU.
According to Airfinity, a science information and analytics company, under the new vaccine supply deals on and increase of production capacities, the EU will be able to vaccinate up to 75 percent of its adult population by the end of August 2021, two months ahead of the initial vaccination plan.
The population of the European Union is about 450 million.Official Brussels has contracted amount to nearly 2.3 billion doses of the vaccine at the stage of its development.
So far, the use of three drugs has been approved; relevant contracts have been concluded with the manufacturers.However, many countries are faced with undersupply of vaccines and breach by drug manufacturers of their obligations, informs Bloomberg.